What is the recommended treatment for Clostridium difficile infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Clostridium difficile Infection

For initial episodes of Clostridium difficile infection (CDI), either vancomycin 125 mg orally four times daily or fidaxomicin 200 mg orally twice daily for 10 days is recommended as first-line therapy over metronidazole. 1, 2

Treatment Based on Disease Severity

Non-severe CDI

  • Definition: WBC ≤15,000 cells/mL and serum creatinine <1.5 mg/dL
  • First-line treatment:
    • Vancomycin 125 mg orally four times daily for 10 days, OR
    • Fidaxomicin 200 mg orally twice daily for 10 days 1, 2
  • Alternative (if access to vancomycin or fidaxomicin is limited):
    • Metronidazole 500 mg orally three times daily for 10 days 1
    • Note: Avoid repeated or prolonged courses of metronidazole due to risk of cumulative and potentially irreversible neurotoxicity 1

Severe CDI

  • Definition: WBC ≥15,000 cells/mL or serum creatinine >1.5 mg/dL
  • Treatment:
    • Vancomycin 125 mg orally four times daily for 10 days, OR
    • Fidaxomicin 200 mg orally twice daily for 10 days 1

Fulminant CDI

  • Definition: Hypotension, shock, ileus, or megacolon
  • Treatment:
    • Vancomycin 500 mg orally four times daily, AND
    • Intravenous metronidazole 500 mg every 8 hours 1, 2
    • If ileus is present: Add rectal vancomycin 500 mg in 100 mL normal saline every 6 hours as a retention enema 1

Treatment of Recurrent CDI

First Recurrence

  • If metronidazole was used initially:
    • Vancomycin 125 mg orally four times daily for 10 days 1, 2
  • If standard vancomycin was used initially:
    • Vancomycin in a tapered and pulsed regimen (e.g., 125 mg four times daily for 10-14 days, then twice daily for 7 days, then once daily for 7 days, then every 2-3 days for 2-8 weeks), OR
    • Fidaxomicin 200 mg twice daily for 10 days 1, 3

Second or Subsequent Recurrence

  • Options include:
    • Vancomycin in a tapered and pulsed regimen, OR
    • Vancomycin 125 mg four times daily for 10 days followed by rifaximin 400 mg three times daily for 20 days, OR
    • Fidaxomicin 200 mg twice daily for 10 days, OR
    • Fecal microbiota transplantation (after at least 2 recurrences with appropriate antibiotic treatment) 1, 2

Pediatric Treatment

  • For children with non-severe CDI:
    • Vancomycin 10 mg/kg/dose (maximum 125 mg) orally four times daily for 10 days, OR
    • Metronidazole 7.5 mg/kg/dose (maximum 500 mg) orally three or four times daily for 10 days 1, 2

Important Considerations

Discontinue Inciting Antibiotics

  • Stop the inciting antibiotic agent(s) as soon as possible to reduce the risk of CDI recurrence 1

Monitoring Response

  • Expect decreased stool frequency and improved consistency within 3 days of starting treatment 2
  • If no improvement after 3-5 days, reassess severity and consider changing treatment approach

Avoid

  • Antiperistaltic agents and opiates as they may mask symptoms and potentially worsen disease 2
  • High-dose vancomycin (500 mg four times daily) has not shown superior efficacy compared to standard dose (125 mg four times daily) for non-fulminant CDI 4, 5

Surgical Considerations

  • Early surgical consultation for patients with severe complications:
    • Perforation of the colon
    • Systemic inflammation not responding to antibiotics
    • Toxic megacolon or severe ileus
    • Elevated serum lactate 1, 2

Evidence Strength

  • The recommendation for vancomycin or fidaxomicin over metronidazole is based on high-quality evidence 1
  • Fidaxomicin has been shown to have similar clinical cure rates to vancomycin but with significantly lower recurrence rates (15.4% vs. 25.3%) 6
  • For first recurrences, fidaxomicin has demonstrated lower second recurrence rates compared to vancomycin (19.7% vs. 35.5%) 3
  • The efficacy of fecal microbiota transplantation for multiple recurrent CDI is supported by moderate quality evidence 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Clostridioides difficile Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012

Research

Fidaxomicin versus vancomycin for Clostridium difficile infection.

The New England journal of medicine, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.